Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

The aim of this systematic review was to study the benefits and risks of beta-adrenergic antagonists (beta-blockers) in patients with chronic kidney disease (CKD).